Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kyprolis
Kyprolis
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
Thu, 12/2/21 - 10:57 am
JNJ
Sanofi
Multiple Myeloma
Sarclisa
Kyprolis
Darzalex
Sanofi keeps nipping at J&J's heels as Sarclisa notches new FDA approval in multiple myeloma
Endpoints
Thu, 04/1/21 - 10:53 am
Sanofi
JNJ
Sarclisa
Kyprolis
Multiple Myeloma
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
Sanofi takes aim at J&J's myeloma star Darzalex with latest Sarclisa trial win
Fierce Pharma
Tue, 05/12/20 - 12:01 pm
Sanofi
Sarclisa
Multiple Myeloma
Amgen
Kyprolis
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Fierce Pharma
Mon, 09/16/19 - 09:25 am
Amgen
Kyprolis
JNJ
Darzalex
Multiple Myeloma
Can Amgen's new-and-improved Kyprolis kick-start myeloma sales?
Fierce Pharma
Fri, 08/31/18 - 11:53 pm
Amgen
Kyprolis
Multiple Myeloma
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Wed, 04/25/18 - 10:54 pm
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
Amgen kicks off 2018 with double the good news for slow-growing Kyprolis
Fierce Pharma
Thu, 01/18/18 - 10:30 pm
Amgen
Kyprolis
Multiple Myeloma
Amgen's Kyprolis improves overall survival in blood cancer patients
Reuters
Tue, 12/12/17 - 10:47 pm
Amgen
Kyprolis
Multiple Myeloma
What Kyprolis Could Do for Amgen’s Revenue Growth
Market Realist
Tue, 08/15/17 - 09:38 am
Kyprolis
Amgen
Multiple Myeloma
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Fierce Pharma
Fri, 07/14/17 - 07:54 am
Amgen
Kyprolis
Revlimid
Celgene
Takeda
Velcade
Multiple Myeloma
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Yahoo/Reuters
Tue, 02/28/17 - 11:12 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Amgen’s Backup Plan for Kyprolis (AMGN)
Investopedia
Sun, 10/2/16 - 10:22 am
Amgen
Kyprolis
Multiple Myeloma
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Amgen
Kyprolis
clinical trials
Multiple Myeloma
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment
Yahoo/Benzinga
Fri, 05/27/16 - 10:43 pm
Amgen
CHMP
Kyprolis
Multiple Myeloma
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Stat
Mon, 05/16/16 - 03:55 pm
Multiple Myeloma
Amgen
Kyprolis
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Amgen balks over meeting to review cost of bone cancer drugs
Stat
Thu, 04/7/16 - 09:46 am
Amgen
drug pricing
Kyprolis
Multiple Myeloma
Pages
1
2
3
4
next ›
last »